HF is associated with an increased risk for arrhythmia and efsevin was previously suggested to suppress arrhythmogenesis in cardiomyocytes13,14 suggesting a role for VDAC2 also as a protective pathway against arrhythmia. This evidence concerns the gene VDAC2 and cardiac arrhythmia.